TrialCephalalgia : an international journal of headache2010

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

H C Diener et al.PubMed ↗Publisher ↗

No numbers read from the abstract.